另一方面，科创50和科创100实现了体系内样本的有序互换，科创50调入样本来自科创100，而科创50调 出样本则相应转入科创100，二者协同联动共同表征科创板大中市值证券表现。科创50与科创100实现对 科创板六大行业全面覆盖，新兴行业结构多元，科创50新一代信息技术行业权重提升约2%，科创100新 材料、生物医药等其他行业提升约4%。 近年来，上交所持续完善"一体两翼"指数体系，加快提升指数体系质量和多样性，强化服务新质生产力 发展和高水平科技自立自强的能力，有效支持中长期资金入市，服务国家重点战略落地。 2月27日，中证指数有限公司发布关于科创50等指数一季度定期调整结果的公告。根据指数编制规则， 科创50等科创指数样本每季度进行定期调整，本次调整将于3月13日收市后实施。 科大国盾量子技术股份有限公司、深圳中科飞测科技股份有限公司、中科星图股份有限公司将被调入科 创50指数，北京热景生物技术股份有限公司、陕西斯瑞新材料股份有限公司、上海君实生物医药科技股 份有限公司等10只证券将被调入科创100指数。 此次样本调整后，一方面，科创宽基指数对科创板市场的代表性进一步提升。调整后，科创50指数总市 值4.5 ...

投资者结构持续优化 (●) 机构持有股票市值占比提升至 2l.l% 平均股息率 2.4% 股票市值 (全球排名第三位) ⊙ 65万亿元 ... .. .. .. .. ◇) 持续完善指数及产品体系 新发布科创综指 为市场全面了解科创板运行整体情况提供表征 沪市ETF规模 (亚洲第二大ETF市场) (●) 4.2万亿元 同比增长 55% 同比增长 其中: 债券ETF规模 约6000亿元 291% 科创债ETF规模1994亿元 融资功能有效发挥 远超2024年 IPO受理66家 同比增长31.3% IPO上市42家 股票首发融资额812.9亿元 | 同比增长1.5倍 : ・・・・・ 股票再融资额9602亿元 同比增长3.8倍 聚焦服务新质雪音力 科创成长层新上市禾元生物、摩尔线程、沐曦股份等 6家企业 科创成长层已汇聚39家企业(截至2026年2月13日) 同比增长 科创板新增股权融资 1073亿元 2.8倍 并购市场活力进发 新增披露资产重组 其中: 重大资产重组 9|4家次 95家次 同比增长 3 830% 大型吸收合并、多元支付等创新示范性项目相继涌现 沪市围绕新质生产力的并购重组占比 近7成 债券市场提质 ...

2月11日，易思维（杭州）科技股份有限公司登陆上交所科创板。至此，科创板上市公司总数达到 604家。 分行业看，集成电路、生物医药行业景气度明显回升。其中，集成电路产业受人工智能等新兴应用 需求拉动，延续较高景气度。87家公司披露业绩情况显示，合计净利润同比增加约99.49亿元，57家公 司业绩预增或扭亏为盈。 创新药行业则凭借商务拓展交易活跃、出海提速，商业化进程显著加快，招采回暖推动制药类公司 业绩回升。数据显示，26家创新药公司合计实现净利润增加14.49亿元，已披露营业收入的18家公司合 计实现营收241.57亿元，同比增长34.9%。 作为中国"硬科技"企业聚集地，科创板的板块产业图谱与现代化产业体系建设同向而行，尤其是在 新一代信息技术、生物医药、高端装备制造等战略性新兴产业领域，已形成"链主引领、上下协同"的发 展格局。 与此同时，板块业绩成长韧性凸显。截至2月9日，科创板已有391家公司以业绩预告或快报形式披 露2025年度预计业绩，其中近六成净利润实现同比增长。 "科创板上市公司已超过600家，这不仅是一个数量里程碑，它标志着这块'试验田'已茁壮成长为中 国硬科技创新的战略基座与资本市场改革 ...

Group 1 - The core viewpoint of the news indicates a collective adjustment in hard technology sectors such as CPO, storage chips, and semiconductor equipment, with a decline in AI application concepts as of the morning session on February 11 [1] - The ChiNext 100 Index, ChiNext 200 Index, and ChiNext Composite Index all experienced a drop of 0.5%, while the ChiNext 50 Index and ChiNext Growth Index fell by 0.9% [1] Group 2 - The ChiNext 200 ETF is designed to track the ChiNext 200 Index, which consists of 200 stocks from the ChiNext board that are smaller in market capitalization and have good liquidity, focusing on small-cap "growth potential" technology enterprises [7] - The electronic and biomedical sectors, along with machinery equipment, account for nearly 70% of the ChiNext 200 Index, with the electronic sector having a significant share [7] - The ChiNext Composite Index ETF aims to track the comprehensive index of the ChiNext board, covering large, medium, and small-cap styles, with a focus on artificial intelligence, semiconductors, and new energy [7]

自2025年1月20日正式发布以来，上证科创板综合指数(简称"科创综指")已平稳运行一年。作为刻画科 创板"全景图"的指数，科创综指在表征市场整体表现与引导长期资金配置方面的作用日益凸显。 数据显示，截至2月10日，科创综指样本数量达580只，市值覆盖度超过90%，总市值高于100亿元的科 创综指成分股权重占比较发布时提升15.1%，成长效应显著。 科创板自设立以来，先后推进试点注册制、"科创板八条""科创板1+6"三轮系统性改革，着力提高资本 市场制度包容性、适应性。截至2月10日，科创板累计支持61家未盈利企业、9家特殊股权架构企业、7 家红筹企业、23家第五套标准企业上市。未盈利上市企业中22家上市后成功盈利"摘U"。 科创板公司坚持创新驱动发展，持续加大创新要素投入力度，创新成果积极涌现。2025年前三季度，科 创板公司研发投入总额达1328.64亿元，是板块净利润的2.7倍；研发投入占营业收入比例中位数为 12.5%，远高于A股其他板块。 并购重组市场日益活跃，自"科创板八条"发布以来，板块新增并购交易170余单、金额超900亿元，交易 达成率近七成；2025年以来发布重大资产重组39单，数量超过前 ...

大河财立方记者 王宇 文 2月10日，科创板又迎来新兵电科蓝天，科创板上市公司总数目前已达603家。 大河财立方记者从上交所获悉，推出一年来，科创综指的市场关注度持续提升。截至2026年2月10日， 科创综指样本数量达580只，市值覆盖度超过90%，总市值高于100亿元的科创综指成份股权重占比较发 布时提升15.1%，成长效应显著。 据了解，科创综指已成为与上证指数、深证成指、创业板指并列的A股四大核心宽基指数，为境内外投 资者观测和分享中国新质生产力发展红利提供了重要工具。 科创综指涨幅达约63% 自2025年初发布以来，科创综指走势呈现出稳步向上的特征。其定位是覆盖科创板全市场的综合指数， 板块市值覆盖度超过90%，可以说是分享科创板公司成长发展成果的有力指标。 截至2026年2月10日，指数涨幅达到约63%。指数发布以来受到投资者的广泛认可，相关产品布局迅速 完善，已形成包括ETF、联接基金、增强型产品在内的完整产品链条，为各类投资者分享新质生产力发 展红利提供了高效、便捷的工具。 截至2026年2月9日，境内已有49家基金管理人推出共81只科创综指指数基金，场内外合计规模达258亿 元。上交所上市科创 ...

Group 1 - The Sci-Tech Innovation Board Composite Index (Sci-Tech Index) has been operating smoothly for one year since its official release on January 20, 2025, and has become a key tool for investors to observe and share the dividends of China's new productive forces [2] - As of February 10, 2025, the Sci-Tech Index covers 580 samples with a market capitalization coverage exceeding 90%, and the weight of constituent stocks with a total market value above 10 billion yuan has increased by 15.1% since its release [2] - The index has gained recognition among investors, with a total of 49 fund managers launching 81 index funds related to the Sci-Tech Index, achieving a combined scale of 25.8 billion yuan as of February 9, 2025 [4] Group 2 - The Sci-Tech Board has gathered over 600 companies, with the latest addition being the listing of Yuhang Power on February 10, 2025, marking it as the 603rd listed company [5] - The total R&D investment of Sci-Tech Board companies reached 132.864 billion yuan in the first three quarters of 2025, which is 2.7 times the net profit of the board, with a median R&D investment ratio of 12.5% of operating income, significantly higher than other A-share sectors [5] - As of February 9, 2025, 391 companies on the Sci-Tech Board have disclosed their expected performance for 2025, with over 60% of them reporting a year-on-year increase in net profit [6] Group 3 - The integrated circuit and biopharmaceutical industries are experiencing a recovery in prosperity, with 87 companies in the integrated circuit sector expected to see a combined net profit increase of approximately 9.949 billion yuan due to demand from emerging applications like artificial intelligence [7] - In the innovative drug sector, 26 companies are projected to increase their net profit by 1.449 billion yuan in 2025, with 18 companies reporting a total revenue of 24.157 billion yuan, reflecting a year-on-year growth of 34.9% [7]

Core Insights - The Science and Technology Innovation Board (STAR Market) has welcomed a new company, Electric Science and Technology Blue Sky, bringing the total number of listed companies to 603, highlighting its role as a hub for "hard technology" enterprises in China [2] - The STAR Market Composite Index has gained significant attention, with a sample size of 580 stocks and a market capitalization coverage exceeding 90%, indicating a notable growth effect [2][3] - Nearly 60% of STAR Market companies have reported a year-on-year increase in net profit, with 39 companies experiencing a substantial growth of over 100% [3] STAR Market Overview - The STAR Market is characterized by a development pattern of "chain leader guidance and upstream-downstream collaboration," particularly in strategic emerging industries such as new-generation information technology, biomedicine, and high-end equipment manufacturing [2] - The STAR Market Composite Index has become one of the four core broad-based indices in A-shares, providing a vital tool for domestic and international investors to observe and share in the dividends of China's new productive forces [2] Performance and Growth - As of February 9, 2026, 391 companies on the STAR Market have disclosed their expected performance for 2025, with over 60% of them showing a year-on-year increase in net profit [3] - The total R&D investment of STAR Market companies reached 132.864 billion yuan in the first three quarters of 2025, which is 2.7 times the net profit of the sector, with a median R&D investment ratio of 12.5% of operating income, significantly higher than other A-share sectors [3] Reform and Development - The STAR Market has undergone three rounds of systematic reforms aimed at enhancing the inclusiveness and adaptability of the capital market, supporting various types of companies, including unprofitable and special equity structure enterprises [4] - Since the introduction of the "STAR Market Eight Articles," over 170 new merger and acquisition transactions have been recorded, totaling more than 90 billion yuan, with a transaction completion rate of nearly 70% [5] Index and Product Ecosystem - The STAR Market Composite Index has shown a steady upward trend since its launch, with an increase of approximately 63% as of February 10, 2026 [6] - A complete product chain has been established, including ETFs, linked funds, and enhanced products, with 49 fund managers launching a total of 81 STAR Market Composite Index funds, achieving a combined scale of 25.8 billion yuan [6]

2月10日，科创板又迎来新兵电科蓝天。目前，科创板上市公司总数达到603家。 作为中国"硬科技"企业的聚集地，科创板的板块产业图谱与现代化产业体系建设同向而行，尤其在新一 代信息技术、生物医药、高端装备制造等战略性新兴产业，已形成"链主引领、上下协同"的发展格局。 科创综指为观察科创板整体情况和发展态势提供了全局性的视角。推出一年来，科创综指的市场关注度 持续提升，截至2026年2月10日，科创综指样本数量达580只，市值覆盖度超过90%，总市值高于100亿 元的科创综指成份股权重占比较发布时提升15.1%，成长效应显著。 科创综指已成为与上证指数、深证成指、创业板指并列的A股四大核心宽基指数，为境内外投资者观测 和分享中国新质生产力发展红利提供了重要工具。 科创板近六成公司预告净利润同比增长 科创综指是定位于覆盖科创板全市场的综合指数，板块市值覆盖度超过90%。可以说，科创综指是分享 科创板公司成长发展成果的有力指标。 截至2026年2月9日，科创板共有391家公司以业绩预告或快报形式披露了2025年度预计业绩情况，占板 块公司总数的六成以上；另有1家公司芯导科技披露了科创板2025年度首份年报，以营收同比 ...

"未来3～5年科创综指相关产品规模和体量仍有巨大发展空间。" 2月10日，随着新股电科蓝天（688818.SH）上市，科创板上市公司总数达到603家，总市值达到11.44万 亿元。 截至目前，科创板逾390家公司以业绩预告或快报形式披露了2025年度预计业绩情况，占板块公司总数 的超六成；另有1家公司披露了科创板2025年度首份年报。从细分行业表现看，集成电路、生物医药行 业景气度回升。 科创综指为观察科创板整体情况和发展态势提供了全局性的视角。截至2月10日，科创综指样本数量达 580只，市值覆盖度超过90%，总市值高于100亿元的科创综指成份股权重占比较发布时提升15.1%。 东吴证券首席经济学家、研究所联席所长芦哲对第一财经称，预期未来3～5年，科创板总市值有望翻 倍，科创综指将同步成长为"万亿级产品规模、千亿级日成交"的核心宽基指数，不仅与沪深300、创业 板指并驾齐驱，更可能率先完成"本土指数—跨境ETF—全球定价"的三级跳，成为中国科技创新实力对 外展示的"首张名片"。 391家公司"交卷"，六成预增 目前，科创板上市公司数量合计603家，包括61家未盈利企业、9家特殊股权架构企业、7家红筹企业、 ...